Yagihashi A - Search Results

1

Detection of anti-livin antibody in gastrointestinal cancer patients.

Yagihashi A, Asanuma K, Tsuji N, Torigoe T, Sato N, Hirata K, Watanabe N. Yagihashi A, et al. Clin Chem. 2003 Jul;49(7):1206-8. doi: 10.1373/49.7.1206. Clin Chem. 2003. PMID: 12816927 No abstract available.

2

Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients.

Nakamura M, Tsuji N, Asanuma K, Kobayashi D, Yagihashi A, Hirata K, Torigoe T, Sato N, Watanabe N. Nakamura M, et al. Among authors: yagihashi a. Cancer Sci. 2004 Jan;95(1):44-51. doi: 10.1111/j.1349-7006.2004.tb03169.x. Cancer Sci. 2004. PMID: 14720326 Free PMC article.

3

Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.

Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N. Tanabe H, et al. Among authors: yagihashi a. Lung Cancer. 2004 Dec;46(3):299-304. doi: 10.1016/j.lungcan.2004.05.002. Lung Cancer. 2004. PMID: 15541814

4

Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.

Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Shijubo Y, Abe S, Hirohashi Y, Torigoe T, Sato N, Watanabe N. Yagihashi A, et al. Lung Cancer. 2005 May;48(2):217-21. doi: 10.1016/j.lungcan.2004.11.002. Epub 2005 Jan 8. Lung Cancer. 2005. PMID: 15829321

5

Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.

Yagihashi A, Ohmura T, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, Sato N, Hirata K, Watanabe N. Yagihashi A, et al. Clin Chim Acta. 2005 Dec;362(1-2):125-30. doi: 10.1016/j.cccn.2005.06.009. Epub 2005 Jul 18. Clin Chim Acta. 2005. PMID: 16026775

6

Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR.

Komatsu M, Kobayashi D, Saito K, Furuya D, Yagihashi A, Araake H, Tsuji N, Sakamaki S, Niitsu Y, Watanabe N. Komatsu M, et al. Among authors: yagihashi a. Clin Chem. 2001;47(7):1297-301. Clin Chem. 2001. PMID: 11427462

7

Detection of anti-survivin antibody in gastrointestinal cancer patients.

Yagihashi A, Asanuma K, Nakamura M, Araya J, Mano Y, Torigoe T, Kobayashi D, Watanabe N. Yagihashi A, et al. Clin Chem. 2001 Sep;47(9):1729-31. Clin Chem. 2001. PMID: 11514420 No abstract available.

8

Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.

Saito K, Yagihashi A, Nasu S, Izawa Y, Nakamura M, Kobayashi D, Tsuji N, Watanabe N. Saito K, et al. Among authors: yagihashi a. Jpn J Cancer Res. 2002 Mar;93(3):253-8. doi: 10.1111/j.1349-7006.2002.tb02166.x. Jpn J Cancer Res. 2002. PMID: 11927006 Free PMC article.

9

Survivin mRNA expression in patients with breast cancer.

Nasu S, Yagihashi A, Izawa A, Saito K, Asanuma K, Nakamura M, Kobayashi D, Okazaki M, Watanabe N. Nasu S, et al. Among authors: yagihashi a. Anticancer Res. 2002 May-Jun;22(3):1839-43. Anticancer Res. 2002. PMID: 12168879

10

Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells.

Yamada K, Yagihashi A, Yamada M, Asanuma K, Moriai R, Kobayashi D, Tsuji N, Watanabe N. Yamada K, et al. Among authors: yagihashi a. Anticancer Res. 2002 Mar-Apr;22(2B):1315-20. Anticancer Res. 2002. PMID: 12168944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters